Wockhardt
Dr Reddy’s to acquire select businesses of Wockhardt for Rs1.850 cr
13 Feb 2020
Wockhardt would transfer 62 of its brands in therapy areas such as Respiratory, Neurology, VMS, Dermatology, Gastroenterology, Pain and Vaccines as also its plant in Baddi, Himachal Pradesh along with all employees, including related sales and marketing teams to Dr Reddy’s on a slump sale basis
Wockhardt Q2 net plunges 97% on US export ban
04 Nov 2014
FDA hits Wockhardt again; this time over Illinois plant
04 Jun 2014
Wockhardt again faces strictures from the US FDA – this time over its facility in Chicago in Illinois
FDA forces Wockhardt to withdraw yet another generic drug from US
17 May 2014
Amid mounting troubles for India’s generic drugs industry, Wockhardt Ltd is recalling over 100,000 bottles of a high blood pressure drug from the US market after they failed to meet FDA standards
Wockhardt Q3 net down 29% at Rs304 crore
10 Feb 2014
